Annual CAPEX
$1.31 M
-$5.01 M-79.34%
December 31, 2023
Summary
- As of February 12, 2025, BBIO annual capital expenditures is $1.31 million, with the most recent change of -$5.01 million (-79.34%) on December 31, 2023.
- During the last 3 years, BBIO annual CAPEX has fallen by -$6.21 million (-82.63%).
- BBIO annual CAPEX is now -97.29% below its all-time high of $48.25 million, reached on December 31, 2021.
Performance
BBIO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$1.73 M
-$715.00 K-29.22%
September 30, 2024
Summary
- As of February 12, 2025, BBIO quarterly capital expenditures is $1.73 million, with the most recent change of -$715.00 thousand (-29.22%) on September 30, 2024.
- Over the past year, BBIO quarterly CAPEX has increased by +$1.30 million (+298.16%).
- BBIO quarterly CAPEX is now -95.82% below its all-time high of $41.46 million, reached on September 30, 2021.
Performance
BBIO Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$6.11 M
+$1.30 M+27.08%
September 30, 2024
Summary
- As of February 12, 2025, BBIO TTM capital expenditures is $6.11 million, with the most recent change of +$1.30 million (+27.08%) on September 30, 2024.
- Over the past year, BBIO TTM CAPEX has increased by +$4.80 million (+367.53%).
- BBIO TTM CAPEX is now -87.48% below its all-time high of $48.76 million, reached on June 30, 2022.
Performance
BBIO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
BBIO CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -79.3% | +298.2% | +367.5% |
| 3 y3 years | -82.6% | +298.2% | +367.5% |
| 5 y5 years | - | +298.2% | +367.5% |
BBIO CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -97.3% | at low | -55.6% | >+9999.0% | -87.5% | +367.5% |
| 5 y | 5-year | -97.3% | at low | -95.8% | +330.0% | -87.5% | +1741.4% |
| alltime | all time | -97.3% | at low | -95.8% | +330.0% | -87.5% | +1741.4% |
BridgeBio Pharma CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.73 M(-29.2%) | $6.11 M(+27.1%) |
| Jun 2024 | - | $2.45 M(+64.0%) | $4.80 M(+72.5%) |
| Mar 2024 | - | $1.49 M(+243.0%) | $2.79 M(+113.3%) |
| Dec 2023 | $1.31 M(-79.3%) | $435.00 K(+0.9%) | $1.31 M(-21.9%) |
| Sep 2023 | - | $431.00 K(+0.7%) | $1.67 M(-16.4%) |
| Jun 2023 | - | $428.00 K(+3466.7%) | $2.00 M(-63.5%) |
| Mar 2023 | - | $12.00 K(-98.5%) | $5.47 M(-13.4%) |
| Dec 2022 | $6.32 M | $801.00 K(+5.5%) | $6.32 M(-21.5%) |
| Sep 2022 | - | $759.00 K(-80.5%) | $8.06 M(-83.5%) |
| Jun 2022 | - | $3.90 M(+354.2%) | $48.76 M(+3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $859.00 K(-66.1%) | $47.14 M(-2.3%) |
| Dec 2021 | $48.25 M(+541.7%) | $2.54 M(-93.9%) | $48.25 M(+0.8%) |
| Sep 2021 | - | $41.46 M(+1712.9%) | $47.86 M(+589.3%) |
| Jun 2021 | - | $2.29 M(+16.6%) | $6.94 M(+38.8%) |
| Mar 2021 | - | $1.96 M(-8.6%) | $5.00 M(-33.5%) |
| Dec 2020 | $7.52 M(+185.0%) | $2.15 M(+290.9%) | $7.52 M(+62.8%) |
| Sep 2020 | - | $549.00 K(+58.7%) | $4.62 M(+3.8%) |
| Jun 2020 | - | $346.00 K(-92.3%) | $4.45 M(+8.4%) |
| Mar 2020 | - | $4.48 M(-694.6%) | $4.11 M(-1203.5%) |
| Dec 2019 | $2.64 M | -$753.00 K(-297.6%) | -$372.00 K(-197.6%) |
| Sep 2019 | - | $381.00 K | $381.00 K |
FAQ
- What is BridgeBio Pharma annual capital expenditures?
- What is the all time high annual CAPEX for BridgeBio Pharma?
- What is BridgeBio Pharma annual CAPEX year-on-year change?
- What is BridgeBio Pharma quarterly capital expenditures?
- What is the all time high quarterly CAPEX for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly CAPEX year-on-year change?
- What is BridgeBio Pharma TTM capital expenditures?
- What is the all time high TTM CAPEX for BridgeBio Pharma?
- What is BridgeBio Pharma TTM CAPEX year-on-year change?
What is BridgeBio Pharma annual capital expenditures?
The current annual CAPEX of BBIO is $1.31 M
What is the all time high annual CAPEX for BridgeBio Pharma?
BridgeBio Pharma all-time high annual capital expenditures is $48.25 M
What is BridgeBio Pharma annual CAPEX year-on-year change?
Over the past year, BBIO annual capital expenditures has changed by -$5.01 M (-79.34%)
What is BridgeBio Pharma quarterly capital expenditures?
The current quarterly CAPEX of BBIO is $1.73 M
What is the all time high quarterly CAPEX for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly capital expenditures is $41.46 M
What is BridgeBio Pharma quarterly CAPEX year-on-year change?
Over the past year, BBIO quarterly capital expenditures has changed by +$1.30 M (+298.16%)
What is BridgeBio Pharma TTM capital expenditures?
The current TTM CAPEX of BBIO is $6.11 M
What is the all time high TTM CAPEX for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM capital expenditures is $48.76 M
What is BridgeBio Pharma TTM CAPEX year-on-year change?
Over the past year, BBIO TTM capital expenditures has changed by +$4.80 M (+367.53%)